Y-Intercept (HK)’s Tarsus Pharmaceuticals TARS Stock Holding History

Y-Intercept (HK)’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.8M	Sell	35,628 -19,043	-35%	-$1.32M	0.06%	461
2026 Q2	$3.44M	Buy	54,671 +43,461	+388%	+$2.78M	0.07%	425
2026 Q1	$786K	Sell	11,210 -2,432	-18%	-$170K	0.01%	1114
2025 Q4	$1.12M	Buy	13,642 +3,168	+30%	+$237K	0.03%	932
2025 Q3	$622K	Buy	+10,474	New	+$516K	0.01%	1179
2025 Q1	–	Sell	-15,118	Closed	-$837K	–	1599
2024 Q4	$837K	Buy	+15,118	New	+$687K	0.06%	498

Other funds holding TARS

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

West Wealth Group Irvine, California $645M AUM 17.37% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Y-Intercept (HK)'s TARS Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Tarsus Pharmaceuticals (TARS) stake by 35% in Q3 2026, selling an estimated $1.32M and leaving 35,628 shares worth $2.8M. The position accounts for 0.06% of the portfolio, ranked #461.

Y-Intercept (HK) first reported a position in TARS in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.44M in Q2 2026. 20 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

Y-Intercept (HK) held 35,628 shares of Tarsus Pharmaceuticals worth $2.8M as of Q3 2026.
Y-Intercept (HK) sold 19,043 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $1.32M.
Tarsus Pharmaceuticals made up 0.06% of Y-Intercept (HK)'s portfolio in Q3 2026, its #461 holding.
Y-Intercept (HK) first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
Y-Intercept (HK)'s Tarsus Pharmaceuticals position peaked at $3.44M in Q2 2026.
20 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.